Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Clinical Pharmacy
CP-088
DO PATIENTS RECEIVE MEDICATIONS ADJUSTED TO THEIR INDIVIDUAL REQUIREMENTS?
CP-086
CD69 A>G (RS11052877) GENETIC POLYMORPHISM ON THE RESPONSE OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS.
CP-081
INNOVATION AND DEVELOPMENT IMPACT OF ACTIVITIES IN ANTIMICROBIAL STEWARDSHIP PROGRAMMES (ASP)
CP-079
FACTOR IX INHIBITOR DEVELOPMENT IN CONGENITAL HAEMOPHILIA B PATIENTS WITH NONACOG ALFA TREATMENT
CP-076
SAFETY PROFILE OF GLATIRAMER ACETATE 40mg
CP-072
CURRENT VENOUS THROMBOEMBOLISM PROPHYLAXIS PERI-CORONARY ARTERY BYPASS GRAFTING AT ST. THOMAS’ HOSPITAL
CP-069
COMPARISON OF THE DURATION OF EFFECT OF TWO HYALURONIC ACIDS IN KNEE OSTEOARTHRITIS
CP-064
EFFECTIVENESS OF NEW DIRECT ACTING ANTIVIRALS FOR CHRONIC HEPATITIS C DEPENDING ON GENOTYPE IN REAL MEDICAL PRACTICE
CP-063
ASSESSMENT OF URINARY 8-HYROXYDEOXYGUANOSINE LEVEL IN DIABETIC CANCER PATIENTS
CP-062
INFLIXIMAB IN REFRACTORY COELIAC DISEASE
CP-058
ANALYSIS OF CHANGES IN MANAGEMENT OF CATHETER RELATED INFECTIONS IN HAEMODIALYSIS AFTER IMPLEMENTATION OF A PROTOCOL
CP-057
OPTIMIZING PHARMACOTHERAPY IN INSTITUTIONALISED ELDERLY PATIENTS: THE ROLE OF HOSPITAL PHARMACISTS
CP-052
ECONOMIC ASPECTS OF THE USE OF CARBAPENEMS IN CRITICALLY ILL PATIENTS
CP-047
EVALUATION OF THE CLINICAL PHARMACISTS IMPACT ON TOTAL PARENTERAL NUTRITION PRESCRIPTION ORDER REVIEW AND PREPARATION IN NEONATAL INTENSIVE CARE UNIT
CP-046
AN ASSESSMENT OF PREFERENCE OF VISUAL AND MANUAL COMPLIANCE AIDS
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
Follow Us